Nevro Corp. (NVRO) News
Filter NVRO News Items
NVRO News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
NVRO News Highlights
- For NVRO, its 30 day story count is now at 3.
- Over the past 15 days, the trend for NVRO's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- OPK are the most mentioned tickers in articles about NVRO.
Latest NVRO News From Around the Web
Below are the latest news stories about NEVRO CORP that investors may wish to consider to help them evaluate NVRO as an investment opportunity.
Why Is OPKO Health (OPK) Down 17.2% Since Last Earnings Report?OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Nevro to Present at Jefferies Healthcare ConferenceNevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that Kevin Thornal, Nevro's CEO and President, will present at the Jefferies Healthcare Conference on Thursday, June 8, 2023 at 10:30 am Eastern Time at the Marriott Marquis Hotel in New York, NY. |
Nevro Corp.'s (NYSE:NVRO) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatioNevro Corp. ( NYSE:NVRO ) shareholders that were waiting for something to happen have been dealt a blow with a 26... |
Nevro Corp. Announces New Employment Inducement Grant under Section 303A.08 of the NYSE Listed Company ManualNevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced on April 24, 2023, the Board of Director of Nevro granted restricted stock unit awards covering an aggregate of 135,623 shares of its common stock (the RSU Award) and performance unit awards covering 135,623 shares of its common stock (the PSU Award and together, the Awards) to Kevin Thornal, who joined Nevro as its Chief Executive |
Nevro (NVRO) Q1 Earnings and Revenues Surpass EstimatesNevro's (NVRO) worldwide revenues improve on a year-over-year basis in Q1, partly owing to robust domestic performance. |
Q1 2023 Nevro Corp Earnings CallQ1 2023 Nevro Corp Earnings Call |
Nevro (NVRO) Reports Q1 Loss, Tops Revenue EstimatesNevro (NVRO) delivered earnings and revenue surprises of 7.55% and 1.06%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock? |
Nevro Reports First Quarter 2023 Financial Results, Provides Second Quarter Guidance and Reiterates Full-Year 2023 GuidanceNevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its first quarter 2023 financial results. The company also provided second quarter guidance and reiterated its full-year 2023 guidance. |
Ecolab (ECL) to Report Q1 Earnings: What's in the Offing?Ecolab's (ECL) first-quarter results are likely to reflect continued strength in its Global Industrial segment. |
MedTech Stocks' Q1 Earnings Due on Apr 26: MMSI, CNMD & MoreMedical Device players are expected to have benefited from the reopening of economies and several efforts to combat staffing challenges. Let's see how MMSI, CNMD, NVRO and ARAY are likely to have performed this time. |